Bloomberg reports people with schizophrenia taking GLP-1s for diabetes had fewer psychiatric hospital visits, hinting at another possible benefit.
Recap by typeshit. Full story at Bloomberg.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
Eligible workers get certain Type 2 diabetes GLP-1 drugs free as part of a benefits expansion covering more than 250 prescriptions, even as starter plan premiums rise.
Technology Networks reports that people with the fatty liver disease MASLD who took GLP-1 drugs had lower mortality and fewer hospital stays.
Loading…